A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. (Q33488447)

From Wikidata
Revision as of 00:36, 11 March 2019 by QuickStatementsBot (talk | contribs) (‎Added qualifier: series ordinal (P1545): 2, #quickstatements; invoked by SourceMD:ORCIDbot)
Jump to navigation Jump to search
scientific article
Language Label Description Also known as
English
A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer.
scientific article

    Statements

    title
    A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    19640954
    retrieved
    27 July 2017
    main subject
    placebo
    0 references
    biomarker
    0 references
    probiotics
    0 references
    author
    Damien Belobrajdic
    object named as
    Damien Belobrajdic
    series ordinal
    6
    0 references
    Claus T Christophersen
    object named as
    Claus Christophersen
    series ordinal
    5
    0 references
    Kylie-Ann Mallitt
    object named as
    Kylie-Ann Mallitt
    series ordinal
    7
    0 references
    Richard K Le Leu
    object named as
    Richard K Le Leu
    series ordinal
    2
    0 references

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q33488447&oldid=879648845"